PL3219316T3 - Mieszanina kwasów tłuszczowych (grupa kwasów tłuszczowych f.a.g.) do zastosowania w leczeniu patologicznych stanów zapalnych - Google Patents

Mieszanina kwasów tłuszczowych (grupa kwasów tłuszczowych f.a.g.) do zastosowania w leczeniu patologicznych stanów zapalnych

Info

Publication number: PL3219316T3
Authority: PL; Poland
Prior art keywords: fatty acids; mixture; treatment; inflammatory pathologies; group
Prior art date: 2013-03-08

Application number

PL17169929T

Other languages

English (en)

Inventor

Lodovico BURATTIN

Original Assignee

Again Life Italia Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-08

Filing date

2014-03-04

Publication date

2020-06-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3219316(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-04 Application filed by Again Life Italia Srl filed Critical Again Life Italia Srl

2020-06-01 Publication of PL3219316T3 publication Critical patent/PL3219316T3/pl

Links

235000014113 dietary fatty acids Nutrition 0.000 title 2
229930195729 fatty acid Natural products 0.000 title 2
239000000194 fatty acid Substances 0.000 title 2
150000004665 fatty acids Chemical class 0.000 title 2
230000002757 inflammatory effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
230000007170 pathology Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fats And Perfumes (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL17169929T 2013-03-08 2014-03-04 Mieszanina kwasów tłuszczowych (grupa kwasów tłuszczowych f.a.g.) do zastosowania w leczeniu patologicznych stanów zapalnych PL3219316T3 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US201361774796P	2013-03-08	2013-03-08
IT000354A ITMI20130354A1 (it)	2013-03-08	2013-03-08	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
EP17169929.1A EP3219316B1 (en)	2013-03-08	2014-03-04	Mixture of fatty acids (f.a.g., fatty acids group) for use in the treatment of inflammatory pathologies
PCT/EP2014/054163 WO2014135529A1 (en)	2013-03-08	2014-03-04	Mixture of fatty acids for use in the treatment of inflammatory pathologies
EP14708015.4A EP2964215B1 (en)	2013-03-08	2014-03-04	Mixture of fatty acids for use in the treatment of inflammatory pathologies

Publications (1)

Publication Number	Publication Date
PL3219316T3 true PL3219316T3 (pl)	2020-06-01

Family

ID=48227394

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL14708015T PL2964215T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych
PL17169929T PL3219316T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych (grupa kwasów tłuszczowych f.a.g.) do zastosowania w leczeniu patologicznych stanów zapalnych

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL14708015T PL2964215T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych

Country Status (18)

Country	Link
US (2)	US11020365B2 (pl)
EP (2)	EP2964215B1 (pl)
AU (2)	AU2014224710B2 (pl)
CA (1)	CA2904112C (pl)
CY (2)	CY1122248T1 (pl)
DK (2)	DK2964215T3 (pl)
EA (2)	EA035091B1 (pl)
ES (2)	ES2779851T3 (pl)
HR (2)	HRP20191963T1 (pl)
HU (2)	HUE046239T2 (pl)
IT (1)	ITMI20130354A1 (pl)
LT (2)	LT2964215T (pl)
PL (2)	PL2964215T3 (pl)
PT (2)	PT2964215T (pl)
RS (2)	RS60023B1 (pl)
SI (2)	SI2964215T1 (pl)
SM (2)	SMT201900614T1 (pl)
WO (1)	WO2014135529A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20130354A1 (it)	2013-03-08	2014-09-09	Again Life Italia Srl	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
WO2016020828A1 (en) *	2014-08-08	2016-02-11	Raffaele Migliaccio	Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
AR102008A1 (es) *	2015-09-24	2017-01-25	Brix S R L	Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
US20210205253A1 (en) *	2018-05-31	2021-07-08	The Asan Foundation	Use Of Stearic Acid For Preventing Or Treating Pulmonary Fibrosis
EP3586643A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
EP3586641A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
KR102204097B1 (ko) *	2019-01-31	2021-01-18	동신대학교 산학협력단	지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
WO2021163186A1 (en) *	2020-02-12	2021-08-19	Retrotope, Inc.	Deuterated polyunsaturated fatty acids or esters thereof for cosmetic applications
WO2023018703A1 (en) *	2021-08-09	2023-02-16	Kentucky Equine Research, Inc.	Compositions and methods for modulating equine fatty acid profiles
CA3231729A1 (en) *	2021-11-24	2023-06-01	Jenivision Inc.	Delivery methods for treating brain and central nervous system diseases
CN119385999A (zh) *	2024-11-06	2025-02-07	中国人民解放军军事科学院军事医学研究院	壬二酸在制备防治放射性肺损伤药物中的应用
CN120000629B (zh) *	2025-01-22	2025-12-05	华南师范大学	壬二酸在制备防治脓毒症急性肺损伤药物中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0637957B1 (de) *	1992-04-28	1997-07-23	Fresenius AG	Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen
UY24246A1 (es)	1995-06-06	1996-06-14	Neutrogena Corp	Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
EP1175901B1 (en) *	1999-04-15	2006-05-31	Kaneka Corporation	Peroxisome activator-responsive receptor agonists
GB9923738D0 (en)	1999-10-07	1999-12-08	Nestle Sa	Nutritional composition
DE10161729A1 (de)	2001-12-15	2003-06-18	Mira Ursic	Medizinische bzw. pharmazeutische Salbenzubereitung
ATE388689T1 (de)	2002-04-30	2008-03-15	Cognis Ip Man Gmbh	Verwendung von wirkstoffmischungen mit azelainsäure und glycyrrhetinsäure als anti- aknemittel
AU2004224332A1 (en) *	2003-03-20	2004-10-07	Imagenetix, Inc.	Esterified fatty acid composition
US20080057552A1 (en) *	2006-08-31	2008-03-06	Inmok Lee	Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en)	2006-12-20	2009-07-31	Seperex Nutritionals Ltd	An extract
JP4512881B2 (ja) *	2007-11-27	2010-07-28	築中島	薬用油脂
BRPI0909185A2 (pt) *	2008-03-20	2015-08-25	Virun Inc	Derivado de vitamina e e seus usos
US20090264520A1 (en)	2008-04-21	2009-10-22	Asha Lipid Sciences, Inc.	Lipid-containing compositions and methods of use thereof
PT2349250T (pt)	2008-10-31	2017-07-25	Lipid Pharmaceuticals Ehf	Ácidos gordos para uso como um medicamento
CN102438468B (zh)	2009-04-17	2014-06-04	纳塔克制药有限公司	富含低含量植烷酸的ω-3脂肪酸的组合物
ES2548190T3 (es)	2009-09-07	2015-10-14	Epitech Group S.P.A.	Composición que contiene palmitoiletanolamida ultramicronizada
CA2703532C (en)	2010-05-10	2018-05-01	Eva Turley	Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de)	2010-05-27	2011-12-01	Intendis Gmbh	Azelainsäurehaltige Formulierung mit Pigmentzusatz
WO2012094636A2 (en)	2011-01-07	2012-07-12	Elcelyx Therapeutics, Inc.	Chemosensory receptor ligand-based therapies
US20120252888A1 (en) *	2011-03-29	2012-10-04	Palupa Medical Ltd.	Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it) *	2013-03-08	2014-09-09	Again Life Italia Srl	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

2013
- 2013-03-08 IT IT000354A patent/ITMI20130354A1/it unknown
2014
- 2014-03-04 SI SI201431377T patent/SI2964215T1/sl unknown
- 2014-03-04 CA CA2904112A patent/CA2904112C/en active Active
- 2014-03-04 PT PT147080154T patent/PT2964215T/pt unknown
- 2014-03-04 US US14/772,768 patent/US11020365B2/en active Active
- 2014-03-04 WO PCT/EP2014/054163 patent/WO2014135529A1/en not_active Ceased
- 2014-03-04 ES ES17169929T patent/ES2779851T3/es active Active
- 2014-03-04 EP EP14708015.4A patent/EP2964215B1/en active Active
- 2014-03-04 SM SM20190614T patent/SMT201900614T1/it unknown
- 2014-03-04 HR HRP20191963TT patent/HRP20191963T1/hr unknown
- 2014-03-04 AU AU2014224710A patent/AU2014224710B2/en not_active Ceased
- 2014-03-04 EA EA201591680A patent/EA035091B1/ru unknown
- 2014-03-04 PT PT171699291T patent/PT3219316T/pt unknown
- 2014-03-04 LT LT14708015T patent/LT2964215T/lt unknown
- 2014-03-04 DK DK14708015T patent/DK2964215T3/da active
- 2014-03-04 RS RS20200252A patent/RS60023B1/sr unknown
- 2014-03-04 EA EA201791885A patent/EA036724B1/ru unknown
- 2014-03-04 PL PL14708015T patent/PL2964215T3/pl unknown
- 2014-03-04 HU HUE14708015A patent/HUE046239T2/hu unknown
- 2014-03-04 HU HUE17169929A patent/HUE048361T2/hu unknown
- 2014-03-04 ES ES14708015T patent/ES2753257T3/es active Active
- 2014-03-04 SM SM20200115T patent/SMT202000115T1/it unknown
- 2014-03-04 RS RS20191396A patent/RS59523B1/sr unknown
- 2014-03-04 DK DK17169929.1T patent/DK3219316T3/da active
- 2014-03-04 LT LTEP17169929.1T patent/LT3219316T/lt unknown
- 2014-03-04 EP EP17169929.1A patent/EP3219316B1/en active Active
- 2014-03-04 SI SI201431512T patent/SI3219316T1/sl unknown
- 2014-03-04 PL PL17169929T patent/PL3219316T3/pl unknown
2018
- 2018-03-27 AU AU2018202190A patent/AU2018202190B2/en not_active Ceased
2019
- 2019-11-05 CY CY20191101148T patent/CY1122248T1/el unknown
2020
- 2020-03-10 HR HRP20200394TT patent/HRP20200394T1/hr unknown
- 2020-03-16 CY CY20201100229T patent/CY1122783T1/el unknown
2021
- 2021-04-29 US US17/244,036 patent/US20210290578A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2014224710B2 (en)	2018-04-12
EP2964215A1 (en)	2016-01-13
PT2964215T (pt)	2019-11-12
US11020365B2 (en)	2021-06-01
CA2904112C (en)	2021-03-23
CY1122783T1 (el)	2021-05-05
AU2018202190B2 (en)	2019-05-02
RS60023B1 (sr)	2020-04-30
DK3219316T3 (da)	2020-03-16
CA2904112A1 (en)	2014-09-12
EP3219316B1 (en)	2020-02-19
WO2014135529A1 (en)	2014-09-12
CY1122248T1 (el)	2020-11-25
EA035091B1 (ru)	2020-04-27
EA201791885A1 (ru)	2018-01-31
EP3219316A1 (en)	2017-09-20
AU2018202190A1 (en)	2018-04-26
SMT201900614T1 (it)	2020-01-14
DK2964215T3 (da)	2019-11-11
RS59523B1 (sr)	2019-12-31
SI3219316T1 (sl)	2020-07-31
LT3219316T (lt)	2020-04-10
HUE048361T2 (hu)	2020-08-28
EP2964215B1 (en)	2019-08-21
SMT202000115T1 (it)	2020-05-08
US20210290578A1 (en)	2021-09-23
ES2753257T3 (es)	2020-04-07
HUE046239T2 (hu)	2020-02-28
PT3219316T (pt)	2020-03-27
ES2779851T3 (es)	2020-08-20
ITMI20130354A1 (it)	2014-09-09
HRP20200394T1 (hr)	2020-06-12
LT2964215T (lt)	2019-11-25
HRP20191963T1 (hr)	2020-01-24
PL2964215T3 (pl)	2020-03-31
SI2964215T1 (sl)	2019-12-31
AU2014224710A1 (en)	2015-09-10
EA201591680A1 (ru)	2015-12-30
HK1243924A1 (en)	2018-07-27
EA036724B1 (ru)	2020-12-11
US20160015666A1 (en)	2016-01-21

Publication	Publication Date	Title
PT3219316T (pt)	2020-03-27	Mistura de ácidos gordos para utilização no tratamento de patologias inflamatórias
Upson et al.	2012	Where are all the female geniuses?
PL2984076T3 (pl)	2018-04-30	Estry i etery 2,5-tetrahydrofuranu jako plastyfikatory
PL3139770T3 (pl)	2018-08-31	Kompozycja kwasów tłuszczowych, sposób jej wytwarzania i jej zastosowanie
ZA201602970B (en)	2017-07-26	Process for the preparation of iopamidol
IL257143A (en)	2018-03-29	Cetylated fatty acids, a system for their preparation and use
IL245474A0 (en)	2016-06-30	Process for the preparation of 5-fluoro-1h-pyrazoles
IL244755B (en)	2019-10-31	process to create xanthohumol
IL245476A0 (en)	2016-06-30	Process for preparing 5-fluoro-1h-pyrazoles
IL245199A (en)	2017-02-28	Processes for making unsaturated esters
EP3093285A4 (en)	2017-06-21	Gadolinium complex comprising do3a-tranexamic acid conjugate
HUE040536T2 (hu)	2019-03-28	Eljárás halogén-N,N-dimetilbenzilaminok elõállítására
IL229326A (en)	2015-11-30	Process for making n-iodine-affluent
Mighton	2013	For the love of math
SG11201608898UA (en)	2016-12-29	Unsaturated fatty acid absorption accelerator
PL3083976T3 (pl)	2020-11-16	Sposób przygotowania tiacumycyny b
GB201310891D0 (en)	2013-07-31	The Universal Alchemical Egg